Edesa Biotech Inc (EDSA)
4.58
-0.05
(-1.13%)
USD |
NASDAQ |
May 06, 16:00
4.58
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.3112M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -0.1124M |
| December 31, 2018 | -0.2063M |
| September 30, 2018 | -0.2335M |
| June 30, 2018 | -0.2895M |
| March 31, 2018 | -0.3692M |
| December 31, 2017 | -0.365M |
| September 30, 2017 | -0.3062M |
| June 30, 2017 | -0.1426M |
| March 31, 2017 | -0.0189M |
| December 31, 2016 | 0.0311M |
| September 30, 2016 | 0.1439M |
| June 30, 2016 | 0.2044M |
| March 31, 2016 | 0.0746M |
| December 31, 2015 | -0.0259M |
| September 30, 2015 | -0.0816M |
| June 30, 2015 | -0.5016M |
| Date | Value |
|---|---|
| March 31, 2015 | -0.4066M |
| December 31, 2014 | -0.29M |
| August 31, 2014 | -0.3881M |
| May 31, 2014 | -0.0439M |
| February 28, 2014 | -0.0398M |
| November 30, 2013 | -0.0735M |
| August 31, 2013 | -0.0587M |
| May 31, 2013 | -0.1304M |
| February 28, 2013 | -0.1548M |
| November 30, 2012 | -0.2019M |
| August 31, 2012 | -0.2499M |
| May 31, 2012 | -0.7623M |
| February 29, 2012 | -0.7967M |
| November 30, 2011 | -0.3339M |
| August 31, 2011 | -0.3232M |
| May 31, 2011 | 0.6526M |
| February 28, 2011 | 0.7895M |
| November 30, 2010 | 0.4134M |
| August 31, 2010 | 0.4983M |
| May 31, 2010 | 0.0495M |
| January 31, 2010 | 0.00 |
| October 31, 2009 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.3112M
Minimum
Sep 2020
0.3112M
Maximum
Sep 2020
0.3112M
Average
0.3112M
Median
Sep 2020
Gross Profit (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 161.36M |
| Lexaria Bioscience Corp | 0.3684M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |